Skip to main content

Share story

Products

Apple introduces iPhone 17e

Apple introduces iPhone 17e Image: Primary
Apple announced the iPhone 17e on March 2. The new model features the latest generation A19 chip for performance and the C1X cellular modem. The C1X modem is up to twice as fast as the one in the iPhone 16e. The phone includes a 48 megapixel Fusion camera that supports next generation portraits and 4K Dolby Vision video recording. It enables an optical quality 2 times telephoto. The 6.1 inch Super Retina XDR display features Ceramic Shield 2 for three times better scratch resistance and reduced glare. iPhone 17e starts at 256 gigabytes of storage priced at 599 dollars. Preorders begin March 4 with availability on March 11. The phone is available in black, white, and soft pink with a matte finish. It supports MagSafe wireless charging up to 15 watts and satellite features for emergency services, roadside assistance, messages, and Find My outside of cellular coverage. Kaiann Drance, vice president of Worldwide iPhone Product Marketing at Apple, said the product delivers powerful performance and features at an exceptional value. The smartphone uses aerospace grade aluminum and holds an IP68 rating for water and dust resistance. It comes with iOS 26 and supports fast wired charging to 50 percent in around 30 minutes.
Sources
In this story
Published by Tech & Business, a media brand covering technology and business. This story was sourced from Apple and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Capital
Capital

Nominal raises $240 million at a $3 billion valuation

Nominal has raised $240 million at a $3 billion valuation, triple its valuation in a funding round earlier this year, Bloomberg reports. The startup builds software to make manufacturing more efficient.

Capital Products
Capital Products

Onodrim raises $300M to acquire European defence and industrial suppliers

Amsterdam-based Onodrim Industries has raised $300M in a round led by Lux Capital, valuing the defence group at $1.3bn, the company said Monday. Other investors include General Catalyst, Lakestar and Altimeter. The financing follows its €40M seed round in February.

Capital
Capital

SRTD Biotech raises €31.5 million for targeted RNA therapies

SRTD Biotech has completed an oversubscribed €31.5 million seed financing to develop RNA therapies designed to act selectively inside diseased cells. Mérieux Equity Partners led the round, with NRW.BANK and Boehringer Ingelheim Venture Fund joining as co-leads.